Lung cancer Posts on Medivizor
Navigation Menu

Lung cancer Posts on Medivizor

Searching for patients with non-small cell lung cancer to trial an immune treatment

Searching for patients with non-small cell lung cancer to trial an immune treatment

Posted by on Nov 22, 2020 in Lung cancer | 0 comments

In a nutshell This trial is being carried out to examine the effectiveness of a new immune therapy, zimberelimab, alone or in combination with other immune therapies (domvanalimab and etrumadenant) in patients with PD-L1 positive non-small cell lung cancer (NSCLC). The main outcomes to be measured in this trial is the response rate and survival...

Read More

Searching for patients with EGFR-positive advanced tumors to trial an experimental treatment.

Searching for patients with EGFR-positive advanced tumors to trial an experimental treatment.

Posted by on Nov 22, 2020 in Lung cancer | 0 comments

In a nutshell This trial is being carried out to assess the safety and effectiveness of an experimental drug called BCA101 alone and in combination with pembrolizumab (Keytruda) in advanced solid tumors that are EGFR-positive. The main outcomes to be measured are the occurrence of side effects and response to treatment. The details Advanced solid...

Read More

Searching for patients with advanced non-small cell lung cancer to trial a radiation treatment

Searching for patients with advanced non-small cell lung cancer to trial a radiation treatment

Posted by on Nov 8, 2020 in Lung cancer | 0 comments

In a nutshell This trial is looking at the effectiveness of Quad Shot (QS) radiation therapy (RT) to relieve symptoms in patients with advanced non-small-cell lung cancer (NSCLC). The main outcome that is to be measured is the occurrence of side effects over the course of 3-months. This trial is being carried out in New Jersey and New York,...

Read More

Searching for patients with advanced lung cancer to trial a new immune treatment.

Searching for patients with advanced lung cancer to trial a new immune treatment.

Posted by on Nov 8, 2020 in Lung cancer | 0 comments

In a nutshell This trial is looking at the effectiveness, safety, and tolerability of ladiratuzumab vedotin (LV) in patients with advanced solid tumors, including lung cancer. The main outcome to be measured in this trial is the response rate to the new drug. The details Advanced tumors have spread from the organ where they originated. These tumors...

Read More

Effectiveness and safety of atezolizumab compared to platinum-based chemotherapy in the treatment of advanced NSCLC

Effectiveness and safety of atezolizumab compared to platinum-based chemotherapy in the treatment of advanced NSCLC

Posted by on Nov 7, 2020 in Lung cancer | 0 comments

In a nutshell This study looked at the safety and effectiveness of atezolizumab (Tecentriq) compared to platinum-based chemotherapy for the treatment of advanced lung cancer. They found that atezolizumab improved survival compared to chemotherapy in these patients. Some background Lung cancer is classified based on how the tumor cells look...

Read More

Evaluating osimertinib for EGFR positive non-small-cell lung cancer that was surgically removed.

Evaluating osimertinib for EGFR positive non-small-cell lung cancer that was surgically removed.

Posted by on Oct 30, 2020 in Lung cancer | 0 comments

In a nutshell This trial was carried out to assess the effectiveness and safety of osimertinib (Tagrisso) after surgery for EGFR-positive advanced non-small cell lung cancer (NSCLC). The trial found that this treatment improved the outcomes of patients with stage IB to IIIA EGFR-positive NSCLC that was surgically removed. Some...

Read More

Longer survival without progression in patients with NSCLC with nivolumab plus chemotherapy before surgery

Longer survival without progression in patients with NSCLC with nivolumab plus chemotherapy before surgery

Posted by on Oct 25, 2020 in Lung cancer | 0 comments

In a nutshell This study investigated the antitumor activity, safety, and survival after nivolumab (Opdivo) and chemotherapy before surgery for patients with stage IIIA non-small-cell lung cancer (NSCLC). The study showed a high rate of survival without cancer worsening among these patients. Some background NSCLC amounts to over 80% of...

Read More

Osimertinib in EGFR-positive non-small cell lung cancer spread to the brain or the layers surrounding the brain.

Osimertinib in EGFR-positive non-small cell lung cancer spread to the brain or the layers surrounding the brain.

Posted by on Oct 24, 2020 in Lung cancer | 0 comments

In a nutshell This trial was carried out to examine the effectiveness of osimertinib (Tagrisso) in non-small cell lung cancer (NSCLC) that has spread to the brain of the layers of the brain (meninges). The authors concluded that osimertinib showed improved survival and had a good response rate in these patients. Some...

Read More

Can immune checkpoint inhibitors be used in the treatment of extensive-stage small cell lung cancer?

Can immune checkpoint inhibitors be used in the treatment of extensive-stage small cell lung cancer?

Posted by on Oct 18, 2020 in Lung cancer | 0 comments

In a nutshell This article looked at the use of immune checkpoint inhibitors (ICIs) in the treatment of extensive-stage (ES) small cell lung cancer (SCLC). The authors found that the addition of atezolizumab (Tecentriq) or durvalumab (Imfinzi) to first-line platinum-based chemotherapy prolongs survival and improves the quality of life...

Read More

Evaluating pembrolizumab consolidation following chemotherapy and radiation for patients with stage III non-small cell lung cancer.

Evaluating pembrolizumab consolidation following chemotherapy and radiation for patients with stage III non-small cell lung cancer.

Posted by on Oct 10, 2020 in Lung cancer | 0 comments

In a nutshell This trial was carried out to examine the effectiveness of pembrolizumab (Keytruda) consolidation therapy for patients with stage III unresectable non-small cell lung cancer (NSCLC) following a course of chemotherapy and radiation therapy. The authors found that pembrolizumab consolidation improved the outcomes of...

Read More